Eduardo A. Vega

Wrapping up an amazing #HPBSurgery course at @USFCAMLS with virtual hepatectomy, operative standards in liver & pancreas, and thoughtful case discussions. @AHPBA @SSATnews @FujifilmUS @MHepatobiliary

Blessed to be a GI fellow graduate from Mizzou. Time to transition to attending life continuing the medical education mission and help other trainees to achieve their goals like my mentors did. Thank you @EAVegaMD for helping me throughout the process. #graduation2025 #mizzou

Great first day at the 5th Annual Complex HPB Course! Incredible cadaveric labs and engaging talks with upcoming CGSO fellows @SocSurgOnc. Such a high-level, hands-on learning experience. @MoffittNews @DanielAnayaMD @DenboJw @AHPBA @SSATNews @hpb_so @MHepatobiliary…

Thank you @MoffittNews @DanielAnayaMD @DenboJw @MHepatobiliary for the kind invitation to the 5th Annual Complex HPB Course at @USFCAMLS. Honored to join world-class faculty including Dr. M Katz @MDAndersonNews and Dr. S Warner @MayoClinic in such a dynamic and enriching…

🎉 Our latest publication in the @JSurgRes ! We found 🔑 differences in informed consent perspectives between residents and attendings for 🥢 CCY. Proud of advocating for enhanced surgical education! Congrats to @StephCohenMD! 🥳journalofsurgicalresearch.com/article/S0022-… @BIDMCSurgery @SSATNews…

Explore a surgical perspective from Japan on SMA dissection by central vascular ligation during open and robotic pancreatoduodenectomy. A must-watch for those interested in advanced HPB techniques. Watch now: youtube.com/watch?v=69iihu… @EAVegaMD @YosukeInoueHPB #HPBSurgery #SMA

🎥 New #HowIDoIt video from @SSATNews @YosukeInoueHPB and team showcase their open & 🤖 PD with an SMA-🥇 approach – enhancing safety and oncologic outcomes in panc surgery. Watch now ➡️ ssat.com/video/robotic.… @AHPBA @EAHPBA @JSHBPS @chiaro_del @KenichiroUemura @ObaAtsushi…

🆕 @ModernPathology : We analyzed 122 GBC from 🇺🇸 & 🇨🇱 to uncover population-specific immunogenomic differences. 🔍 Similar mutations, but striking immune contrasts 🧬 CD4+VISTA+ cells = poor prognosis 📍 Highlights geographic relevance in GBC IO 🔗 modernpathology.org/article/S0893-……

Our work on NMP and liver transplant waitlist times has just been published - take a look!👇Findings were particularly relevant to patients with HCC on the waitlist @BIDMCTransplant. @CojucG @sicanizaresq @RitahChumdermp1 @dibmartin @BIDMCSurgery @JSurgRes

Our latest research on gallbladder cancer explores T3/T4. Grateful to the team and @EAVegaMD for making this possible. #CancerResearch #GallbladderCancer #OncoSurg #HPBsurgery @IHPBA @AHPBA @TheAhpbaPodcast @CirugiaGralHIBA 🔗 [authors.elsevier.com/c/1lBCe,Op-49r…]

See you there! @HPBCambridge @DrHaleyEllis @gbonneysurg @TorzilliGuido @ItaruEndo @lendoire

Assessment of nodal staging and risk factors for nodal involvement in gallbladder cancer ➡️doi.org/10.1093/bjsope… Node-positive disease in gallbladder cancer is associated with poorer survival. This study showed that the number of positive nodes is the most discriminative nodal…

🚨 New multicenter study on Advanced Gallbladder Cancer (T3/T4) just out @JournalofGISurg ! 👉@MBRiveraMD @ArianaMChirban @ElenaPanettier1 🔍 419 patients from 17 institutions 🔪 OER = high morbidity, esp. in T4 ❗️44% of T3 were incidental 📉 T4 = poor outcomes ⚠️ Caution…

Thank you Eduardo!

Previous open Whipple studies failed to consistently reduce pancreatic fistula. Was it a limitation in execution all along? 🤔 This new single-center study shows a 3x lower CR-POPF rate with robotic PD vs open (10% vs 33.3%) — despite (or bc) not being powered for it. Encouraging…

Check out this new @AnnSurgOncol paper from our group @StElizabethsMC. "Over 44% of patients who were assigned palliative chemotherapy at tumor boards without an liver surgeon were considered potentially resectable upon independent review" 👉 pubmed.ncbi.nlm.nih.gov/33939045/

"It's not only the responsibility of MTB and general surgeons to include a LS in the treatment planning for patients with stage IV CRC, but also the obligation of the LS to effectively communicate and make themselves available"@AnnSurgOncol @AmCollSurgeons

Don't miss our NEXT episode with the incredible @HopSTranCao discussing 🗞️updates in cholangio and 🤖 surgery! @EAVegaMD @vreelant @timnewhook19 @elizcarpenter16 @EAHPBA @IHPBA @AHPBA podcasts.apple.com/us/podcast/epi…

Grateful for the thoughtful letter from @TataMemorial. Our reply in @AnnSurgOncol stresses: refining surgical selection in gallbladder cancer is not optional — it’s an obligation. Modern imaging (EUS, PET-CT) brings preoperative certainty closer than ever.@cureGBC @AHPBA…

Tomorrow @StElizabethsMC don't missed it. @MBRiveraMD @ArianaMChirban @AmairanAlicia @GomezJorgeMD